Skip to main content
Log in

Fertilitätstherapie beim Turner-Syndrom

Möglichkeiten und Grenzen

Fertility therapy in Turner syndrome

Possibilities and limits

  • CME Zertifizierte Fortbildung
  • Published:
Gynäkologische Endokrinologie Aims and scope

An Erratum to this article was published on 03 September 2014

Zusammenfassung

Frauen mit Turner-Syndrom haben eine prämature Ovarialinsuffizienz. Folglich ist ihre Fertilität in den meisten Fällen stark eingeschränkt. Bei Kinderwunsch kommen neben einer selten eintretenden spontanen Schwangerschaft die Verfahren der künstlichen Befruchtung infrage. Biologisch möglich ist die Verwendung autologer (soweit verfügbar) und heterologer Gameten. Der Einsatz heterologer Gameten (Eizellspende, gespendetes Ovargewebe, gespendete Embryonen, Leihmutterschaft) ist in Deutschland verboten. Patientinnen mit Turner-Syndrom haben schwangerschaftsbedingt ein erheblich gesteigertes Morbiditäts- und Mortalitätsrisiko. Insbesondere besteht ein erhöhtes kardiovaskuläres Risiko mit drohender Aortendissektion. Die relative Kontraindikation gegen eine Schwangerschaft aufgrund des erhöhten Risikos ist gegen die subjektiv empfundene Belastung der Kinderlosigkeit abzuwägen. In bestimmten kardiovaskulären Konstellationen ist eine Schwangerschaft absolut kontraindiziert.

Abstract

Women with Turner syndrome comprise a premature ovarian failure. Subsequently their fertility is reduced. For those wishing to conceive a rare spontaneous conception is possible as well as the use of artificial reproductive technology (ART). The utilisation of autologous (if available) and heterologous gametes is biologically feasible. The application of heterologous gametes (oocyte donation, donated ovarian tissue, donated embryos, surrogacy) is not permissible in Germany. Patients with Turner syndrome have a considerably increased morbidity and mortality in pregnancy compared to healthy women. Most importantly they are at elevated cardiovascular risk and are threatened by aortic dissection. The relative contraindication for pregnancy due to increased risk must be balanced against the subjectively perceived challenge of infertility. Certain cardiovascular constellations signify an absolute contraindication for pregnancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Nielsen J, Wohlert M (1990) Sex chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Birth Defects Orig Artic Ser 26:209–223

    CAS  PubMed  Google Scholar 

  2. Hovatta O (2012) Ovarian function and in vitro fertilization (IVF) in Turner syndrome. Pediatr Endocrinol Rev 9(Suppl 2):713–717

    PubMed  Google Scholar 

  3. Sallai A, Sólyom J, Dobos M et al (2010) Y-chromosome markers in Turner syndrome: Screening of 130 patients. J Endocrinol Invest 33:222–227

    Google Scholar 

  4. Modi DN, Sane S, Bhartiya D (2003) Accelerated germ cell apoptosis in sex chromosome aneuploid fetal human gonads. Mol Hum Reprod 9:219–225

    Article  CAS  PubMed  Google Scholar 

  5. Singh RP, Carr DH (1966) The anatomy and histology of XO human embryos and fetuses. Anat Rec 155:369–383

    Article  CAS  PubMed  Google Scholar 

  6. Hagen CP, Aksglaede L, Sørensen K et al (2010) Serum levels of anti-Müllerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients. J Clin Endocrinol Metab 95:5003–5010

    Google Scholar 

  7. Pasquino AM, Passeri F, Pucarelli I et al (1997) Spontaneous pubertal development in Turner’s syndrome. Italian Study Group for Turner’s Syndrome. J Clin Endocrinol Metab 82:1810–1813

    Google Scholar 

  8. Mortensen KH, Rohde MD, Uldbjerg N, Gravholt CH (2010) Repeated spontaneous pregnancies in 45,X Turner syndrome. Obstet Gynecol 115(2 Pt 2):446–449

    Article  PubMed  Google Scholar 

  9. Zacharin M (2010) Disorders of ovarian function in childhood and adolescence: evolving needs of the growing child. An endocrine perspective. BJOG 117:156–162

    Article  CAS  PubMed  Google Scholar 

  10. Hovatta O (1999) Pregnancies in women with Turner’s syndrome. Ann Med 31:106–110

    Article  CAS  PubMed  Google Scholar 

  11. Bondy CA (2007) Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab 92:10–25

    Google Scholar 

  12. Visser JA, Hokken-Koelega ACS, Zandwijken GRJ et al (2013) Anti-Müllerian hormone levels in girls and adolescents with Turner syndrome are related to karyotype, pubertal development and growth hormone treatment. Hum Reprod 28:1899–1907

    Article  CAS  PubMed  Google Scholar 

  13. Bakalov VK, Shawker T, Ceniceros I, Bondy CA (2007) Uterine development in Turner syndrome. J Pediatr 151:528–531, 531.e1

    Google Scholar 

  14. Abir R, Fisch B, Nahum R et al (2001) Turner’s syndrome and fertility: current status and possible putative prospects. Hum Reprod Update 7:603–610

    Article  CAS  PubMed  Google Scholar 

  15. Gonzalez L, Witchel SF (2012) The patient with Turner syndrome: puberty and medical management concerns. Fertil Steril 98:780–786

    Article  PubMed Central  PubMed  Google Scholar 

  16. Schoemaker MJ, Swerdlow AJ, Higgins CD et al (2008) Mortality in women with Turner syndrome in Great Britain: a national cohort study. J Clin Endocrinol Metab 93:4735–4742

    Google Scholar 

  17. Hjerrild BE, Mortensen KH, Gravholt CH (2008) Turner syndrome and clinical treatment. Br Med Bull 86:77–93

    Article  PubMed  Google Scholar 

  18. Matura LA, Ho VB, Rosing DR, Bondy CA (2007) Aortic dilatation and dissection in Turner syndrome. Circulation 116:1663–1670

    Article  PubMed  Google Scholar 

  19. Mortensen KH, Hjerrild BE, Stochholm K et al (2011) Dilation of the ascending aorta in Turner syndrome – a prospective cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 13:24

    Google Scholar 

  20. Ilyas M, Chu C, Ettles D et al (2006) Evaluation by magnetic resonance imaging of aortic dilatation and coarctation in adult Turner syndrome patients. Clin Endocrinol (Oxf) 65:154–157

    Google Scholar 

  21. Practice Committee of American Society For Reproductive Medicine (2012) Increased maternal cardiovascular mortality associated with pregnancy in women with Turner syndrome. Fertil Steril 97:282–284

    Google Scholar 

  22. Karnis MF, Zimon AE, Lalwani SI et al (2003) Risk of death in pregnancy achieved through oocyte donation in patients with Turner syndrome: a national survey. Fertil Steril 80:498–501

    Article  PubMed  Google Scholar 

  23. Conrad KP, Baker VL (2013) Corpus luteal contribution to maternal pregnancy physiology and outcomes in assisted reproductive technologies. Am J Physiol Regul Integr Comp Physiol 304:R69–R72

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  24. Lleo A, Moroni L, Caliari L, Invernizzi P (2012) Autoimmunity and Turner’s syndrome. Autoimmun Rev 11(6–7):A538–A543

    Google Scholar 

  25. Freriks K, Timmermans J, Beerendonk CCM et al (2011) Standardized multidisciplinary evaluation yields significant previously undiagnosed morbidity in adult women with Turner syndrome. J Clin Endocrinol Metab 96:E1517–E1526

    Google Scholar 

  26. Hewitt JK, Jayasinghe Y, Amor DJ et al (2013) Fertility in Turner syndrome. Clin Endocrinol (Oxf) 79:606–614

    Google Scholar 

  27. Practice Committee of American Society For Reproductive Medicine, Society for Assisted Reproductive Technology (2013) Mature oocyte cryopreservation: a guideline. Fertil Steril 99:37–43

    Article  Google Scholar 

  28. Rosendahl M, Greve T, Andersen CY (2013) The safety of transplanting cryopreserved ovarian tissue in cancer patients: a review of the literature. J Assist Reprod Genet 30:11–24

    Google Scholar 

  29. Rosendahl M, Andersen CY, Ernst E et al (2008) Ovarian function after removal of an entire ovary for cryopreservation of pieces of cortex prior to gonadotoxic treatment: a follow-up study. Hum Reprod 23:2475–2483

    Article  PubMed  Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. B. Rösing gibt an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B. Rösing.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rösing, B. Fertilitätstherapie beim Turner-Syndrom. Gynäkologische Endokrinologie 12, 103–112 (2014). https://doi.org/10.1007/s10304-013-0616-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10304-013-0616-9

Schlüsselwörter

Keywords

Navigation